ASXL1Chronic myelomonocytic leukaemia (CMML)myeloproliferative neoplasmsCMML-1Immune cytopeniaCMML
…y better LFS (32.7 vs 8.1 months; p=0.017). After adjusting for ASXL1 and NRAS mutations and haemoglobin <10 g/dL, SIADs remained pro…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ASXL1 ×
ASXL1
This drug is selected. Its supporting articles are shown below.